Antigenic variation is an important factor in viral persistence and disease progression. We analyze immunological changes which occur in response to antigenic mutation during chronic viral infection. Using an established model of viral and immune system dynamics, we determine which qualitative shifts in the immune response can be elicited by the appearance of a new mutant. We find that antigenic mutation can cause dramatic shifts in the magnitude and type of anti-viral immune response. For example, the appearance of a mutant can elicit a new immune response which recognizes the original viral strain. We also find that novel strains of the virus which replicate more slowly than existing viral strains are able to invade and survive, even when the immune system is capable of mounting an immune response against the mutant.
Introduction
A typical viral protein contains several epitopes which may predicts in detail the small number of immune transitions which are likely to occur in response to antigenic mutation. We be recognized by cytotoxic T lymphocytes (CTL). Antigenic therefore demonstrate which immunological changes during variation within the CTL epitope has been demonstrated for chronic infection are consistent with the current understanding the human immunodeficiency virus HIV-1 (1-5, for review, see of viral and immune dynamics. 6) and other viruses (7-12), and may be an important factor for viral persistence and disease progression (13).
We wish to investigate immunological changes which may The emergence of a novel mutation occur in response to the appearance of antigenic mutations during viral infection. We are especially interested in qualitative
In the absence of new mutations or other changes in the shifts in the immune response which may be induced by the microenvironment, populations of virus, infected cells, target appearance of a new strain of the virus. Following on from cells and lymphocytes interact in such a way that each (14), we determine which of these fixpoint transitions are likely population moves toward equilibrium; the possible equilibria to occur during the course of viral infection. and the conditions under which they exist have been This investigation includes two important extensions of described in detail (16). When a novel mutation arises, earlier work: we now explicitly include the effects of a limited however, the conditions under which the new viral strain will population of healthy target cells and we consider situations survive are not obvious nor is the response of the immune in which at least some viral epitopes are variable, while others system to this possible invasion. remain conserved across the viral population. Thus we are It is clear that for the new strain to survive, each cell infected able to present a map of immune transitions which are by the mutant must produce on average more than one newly theoretically likely, possible or forbidden in response to infected cell. Intuitively, we expect that another condition for antigenic escape; we believe that an understanding of these survival might be that the new strain replicates more quickly transitions will become increasingly important as detailed than existing viral sub-types or be able to escape immune characterizations of in vivo CTL specificity become available recognition. In the latter case intuition suggests that the (13,15). Since most putative fixpoint transitions can be invading strain will out-compete and eventually replace the wild-type virus. In the former case we expect that the immune excluded on mathematical or biological grounds, our model the system to reach the new equilibrium, particularly if immune memory is involved (17).
Transitions caused by the first antigenic mutation
In this section, we consider the simple case of an antigenic mutation which arises, and persists, in an otherwise antigenically homogeneous population of virus. We use 'wild-type' to refer to this population, but emphasize that the virus at this stage if antigenically, although not necessarily genetically, uniform. This is the first step towards antigenic viral diversity.
The wild-type virus can exist at steady state either with or without immune control; in the latter case the virus population is kept in check by the availability of healthy target cells. When an antigenic mutation occurs, two additional factors determine less quickly than the wild-type and are the epitopes which are
The CTL response to the infection is either specific to each viral currently recognized by the immune system conserved in the strain (z 1 , z 2 , ... ) or is a 'cross-reactive' response (w) which recognizes novel strain?
an epitope from a conserved region of the viral genome.
By examining the parameter ranges for each transition, we find that most putative transitions are forbidden; for completeness, they are summarized in Fig. 2 . By 'forbidden' we system will respond by mounting a specific response to the mean that there are no possible values of the parameters in the invading viral strain. model which would allow these transitions to occur. Our model In contrast, the analysis that follows demonstrates two predicts that none of the transitions illustrated in Fig. 2 will be counter-intuitive results: (i) viral sub-types which replicate observed during chronic viral infection. In general we see that more slowly than existing viral strains are able to invade and it is rare for a viral strain which replicates more slowly than the persist, even when the immune system is capable of mounting existing viral population to be able to invade; the exceptions to a response against them; (ii) viral sub-types which replicate this rule will be discussed in a later section (Fig. 5 ). more quickly than existing viral strains may co-exist with these Each of the remaining, allowed transitions may occur for precursors after invasion and may cause dramatic shifts in certain clearly defined parameter ranges in the model. The the magnitude or type of immune response elicited.
possibilities outlined below offer a detailed map of which Throughout this paper we use a well-studied dynamic mutants are able to emerge under what circumstances and model of viral replication (16) which is explained in some the changes in the immune response which might occur in detail in the Appendix. The key components of this model are:
consequence.
d x, the population of healthy target cells. Transitions when there is no previous immune response d y i , the population of cells infected by viral strain i. We note First, if the wild-type is in equilibrium controlled only by target that viral strain i has (at least one) epitope which differs cell availability, only a viral strain which replicates more from every other viral strain in the system, but may also effectively can invade. This scenario occurs under the rather have epitopes in common with all other strains-we call unlikely conditions that (i) the mutation confers a selective these 'conserved' epitopes.
advantage to the virus and (ii) there is no immune response d z i , the specific immune response against viral strain i. This to the virus before the mutation arises. immune response specifically recognizes cells infected by When both of these conditions are met, the new strain may strain i, i.e. it responds to at least one of the epitopes which invade and either eliminate or co-exist with the wild-type. The differentiate i from other viral strains.
two strains can only co-exist if an immune response specific d w, the 'cross-reactive' immune response. This immune to the new strain emerges. The four transitions which might response, if it exists, recognizes a conserved epitope. Such occur under these conditions are illustrated in Fig. 3 . epitopes might exist, for example, in conserved regions of the viral genome where mutations are not possible or where
Transitions with a pre-existing immune response and a fastermutations do not lead to immune escape.
replicating mutant Second, we consider the transitions that are possible if (i) the A diagram illustrating this model is shown in Fig. 1 . Please note that by convention we order the viral strains (i ϭ 1, 2, mutation confers a selective advantage to the virus (enables faster replication), but in this case (ii) the wild-type is initially 3 ...) by replication rate, such that strain 1 replicates faster than strain 2, etc. In general we then use y 2 to denote cells under immune control. Under these conditions there are five transitions which can infected by the wild-type virus so that y 1 and y 3 denote cells infected by mutant strains which replicate more or less quickly occur when the new mutant does not escape the current immune response, i.e. when the relevant epitopes are conthan the wild-type respectively.
Finally, we note that the transitions described here will not served; the same five transitions plus one additional transition are possible if the new mutant does escape the current immune be instantaneous; considerable time might be necessary for (y 2 represents the pre-existing virus; y 1 then represents a new viral strain which replicates more quickly than y 2 and y 3 represents a viral strain which replicates less quickly.) If the virus initially exists without immune control (top panel), a viral strain which replicates more slowly than the existing virus can never invade nor can a faster replicator invade and evoke two distinct immune responses (z 1 and z 2 , or z 1 and w). If the virus initially exists with an immune response which recognizes the new viral strain (middle panel), once again a viral strain which replicates more slowly than the existing virus can never invade; in this case the transition illustrated, in which the crossreactive immune response is replaced by two specific immune responses, can also not occur. Finally, if the virus initially exists with an immune response which does not recognize the new viral strain (lower panel), the only forbidden transitions are those in which a viral strain which replicates less quickly invades and replaces the initial viral strain. If a viral strain invades which replicates more quickly and is not recognized by the current immune response, the system may move to any equilibrium involving the co-existence of the two viral strains or the elimination of the original viral sub-type.
Fig. 3.
Transitions from an antigenically homogeneous viral population-no pre-existing immune response. The figure illustrates the four possible transitions which might occur in response to a novel mutation, for an infection in which no immune response is present before the emergence of the mutant. For all transitions the new strain, y 1 , must replicate more quickly than the existing viral population, y 2 . In three cases the mutant out-competes and replaces the wild-type virus and an immune response to the mutant may emerge; in the additional case the two viral sub-types co-exist and an immune response specific to the mutant emerges.
response. Again we find that the mutant can either eliminate or as long as the new mutant is not recognized by the pre-existing immune response which is directed against the wild-type virus. co-exist with the wild-type at equilibrium. All of these possible transitions are illustrated in Fig. 4 . We note an interesting feature After the new slower-replicating mutant invades, the two viral types co-exist. In the transitions illustrated center and right, of these transitions: the novel mutation may cause a qualitative shift in the immune response. Of particular interest here is the either an immune response specific to the new viral strain, or an immune response which recognizes both viral strains, fact that CTL which recognize both viral strains may proliferate less well than those which recognize only the mutant; because will emerge. On the left in Fig. 5 we illustrate the case when a new of competition between immune responses, the cross-reactive immune response may therefore disappear when the mutant mutant emerges but an immune response which recognizes this mutant does not appear in the final equilibrium. This does emerges. An example of such a change will be discussed in greater detail later (see Fig. 7) .
not imply that this equilibrium will only exist if the mutant escapes the immune system; instead it implies that the We reiterate that for any of these transitions to occur, the invading mutant must replicate more quickly than the wild-type; immune response to the mutant is not required to keep the virus population in check. The availability of target cells while this is not the case for the vast majority of mutations, adaptations which enable faster replication may well occur in sustains the mutant population at a frequency which is too small to elicit the proliferation of CTL in response to this mutant. response to the specific microenvironment faced by the virus.
Transitions with a pre-existing immune response and a slower-

Mutations in an antigenically heterogeneous population replicating mutant
Finally, we consider the class of transitions which are most
We would also like to examine the effects of the generation likely to occur: a new mutant arises which replicates less of an antigenic mutant in a heterogeneous population of viral quickly than the existing virus. The three transitions which sub-types. From our analysis of the simpler case, it seems occur under these conditions, starting from y 2 and the specific likely that a shift towards a new steady state might occur, immune response z 2 , are: diversity might change and virus load (mirrored by the number of infected cells at equilibrium) might be adjusted. We also d y 2 , y 3 and z 2 (the invading strain emerges without changing expect that shifts in the type of immune response elicited by the immune response) the viral population might be possible. d y 2 , y 3 , z 2 and z 3 (an immune response specific to the invader also emerges) Antigenic mutation can elicit an immune response against d y 2 , y 3 , z 2 and w (an immune response against a conserved conserved epitopes epitope emerges)
As an example, consider the situation illustrated in Fig. 6 . The top panel illustrates one such fixpoint transition diagramEach of these transitions is illustrated in Fig. 5 . We note that only three transitions are possible in response to a new mutant matically. On the left we see the population of virus which exists as two strains, y 2 and y 3 , each of which is controlled which replicates less quickly than the existing virus population. Each of these transitions is possible even though the immune by a specific immune response. A new mutant arises, y 1 , which replicates more quickly than either of the two existing system is capable of mounting a response against the mutant, Fig. 4 . Transitions from an antigenically homogeneous viral population-pre-existing immune response and faster-replicating mutant. At the top are illustrated the five transitions which can occur in response to a novel mutation, when an immune response pre-exists and the new mutant, y 1 , replicates faster than the existing virus, y 2 . In two cases the two viral sub-types co-exist, and an immune response specific to the mutant emerges. All of these transitions are possible whether or not the new mutant escapes the pre-existing immune response. One additional transition is illustrated below, which is possible only if the mutant escapes recognition by the pre-existing immune response; in this case the two viral sub-types can co-exist with a specific immune response directed against each.
strains. In this example, the emergence of the mutant elicits disappears while the cross-reactive response w emerges. (For a discussion of the oscillatory dynamics of this system, refer both specific (z 1 ) and cross-reactive (w) immune responses, i.e. immune responses emerge which recognize not only the to 18.) From this example it is clear that a new, quickly replicating new epitope but also recognize some epitope which is common to the original viral strains. This transition also causes mutant may cause not only the emergence of an immune response which recognizes every viral strain in the system, the specific immune response against the slowest replicating viral strain (z 3 ) to disappear; the abundance of this strain is but may also cause the disappearance of a specific immune response against another viral strain. now kept at such low levels by the cross-reactive immune response that it does not elicit its own specific immune Antigenic mutation can cause the immune response against response effectively.
conserved epitopes to disappear The lower two panels of Fig. 6 show a numerical simulation of this fixpoint transition. The appearance of the new mutant, y 1 , As a second example, let us consider an immunological system at an equilibrium with both specific and cross-reactive causes a change in the equilibrium values of y 2 and y 3 , but both survive the transition. The specific immune response z 3 immune responses-both conserved and variable epitopes exist, and both are recognized by the immune system. A invading mutant must replicate sufficiently quickly in order to survive, but not so quickly that it elicits an immune response. diagram illustrating this type of transition is shown in the top panel of Fig. 7 . Initially (on the left) three viral strains exist A further note of interest is that the rate at which the abundance of the new 'escape' mutant grows may be very slow. This rate under immune control. When a mutant appears which replicates more quickly than the existing viral strains (y 1 ), a specific depends on the availability of target cells, a population which declines as the mutant population increases. Thus the growth immune response to the invading mutant appears (z 1 ). In this example, however, the appearance of the new mutant also rate of the mutant becomes progressively slower over time. causes the cross-reactive immune response (and the slowest replicating viral strain) to disappear. The lower two panels Discussion show a simulation of this transition; we see that y 4 
disappears
Given the initial state of the viral population and immune and after an interlude when the cross-reactive immune specificity, a restricted set of immunological changes may response w dominates, w also is eliminated from the equiliboccur in response to a novel mutation. We have addressed rium. Thus we find that the emergence of a novel mutation basic qualitative questions such as whether the new mutation can cause the disappearance of other virus sub-types and will survive and co-exist with, or replace, the original viral the disappearance of an immune response, even if that population, and how the immune system may respond to the immune response recognizes an epitope shared by every novel strain. As detailed in vivo characterization of CTL viral strain in the system. specificity becomes available, understanding these transitions will be increasingly important. Since each of these 'Escape' mutations transitions is allowed only for certain well-defined parameter As a final example, we consider a system in which only ranges, the experimental observation of any transition will set specific immune responses are present at equilibrium (Fig. 8) .
limits on quantitative variables such as viral replication rates In this case we simulate a situation in which a new mutant and immunogenicities; conversely, in vivo measurement of arises which replicates less effectively than the slowest replicthese parameters will allow for detailed predictions of the ating strain.
immune changes to be expected during chronic infection. In the example illustrated, the new mutant emerges but is Among this restricted set of possible fixpoint transitions, controlled by the availability of target cells (shown in the third we note in particular three interesting possibilities: panel, x; note the y-axis labels on the right). If this availability is small, the mutant strain may not grow to the frequency (i) We predict that under certain conditions a new mutant viral strain may elicit an immune response which recognecessary to elicit its own specific immune response. Thus even though the immune system in our model has the nizes the original strain. This is possible when the crossreactive epitopes are not expressed at levels high capability to mount a specific (or cross-reactive) immune response against the new mutant, neither occurs and the enough to elicit an immune response before the mutant emerges. To our knowledge, there are no experimental mutant strain grows steadily towards its equilibrium value.
The conditions under which such a mutant is able to invade data yet available with which this question could be addressed, although the characterization of antigen and survive can be deduced from the steady state conditions derived in (16). These conditions give a range of replication specific T lymphocytes during infection is becoming feasible (13,15). rates for which this phenomenon might be observed: the (ii) Our analysis clarifies that mutations which reduce the strain may emerge; eventually the original viral population will co-exist with the novel strain and the novel immune viral replication rate are able to increase in abundance even when the immune system is capable of mounting a response. (iii) We also note examples in which no immune response response against the novel strain. This can only occur, however, when the invading strain initially escapes recogis mounted against the invading strain, even though both cross-reactive and specific immune responses are nition by the pre-existing immune responses, i.e. the immune responses which are elicited by the wild-type available to the immune system. These latter examples are of particular interest because the abundance of virus before the new mutation emerges. As the abundance of the mutant increases an immune response to the new the novel mutant will steadily increase without eliciting an immune response-the viral strain appears to be rather than rapidly out-competing the pre-existing virus [for an interesting clinical example see (13)]. A possible an 'escape' mutant despite the fact that the immune system is capable of mounting a response against it.
avenue for future study is to determine in greater detail the conditions under which this phenomenon can occur, This phenomenon may occur when the replication rate of the mutant is slower than the replication rate of the and to derive realistic growth rates for such escape mutants. For a detailed experimental study of these existing virus (and is in fact too slow to elicit an immune response), but is just fast enough to invade.
phenomena, a method to measure the in vivo replication rate of virus mutants is required, as well as the detailed Under these conditions, the rate of increase of the mutant abundance may be very slow. Thus an apparent CTL specificity of patients against their own virus population. escape mutation grows slowly to a finite abundance, 
